Type 2 diabetes mellitus (T2DM) is an expanding global health problem, closely linked to
the epidemic of obesity. Individuals with T2DM are at high risk for both microvascular …

The heterogeneous pathogenesis and progressive natural history of type 2 diabetes mellitus
(T2DM) contrive a formidable therapeutic challenge. Dual endocrine deficits of impaired …

Type 2 diabetes mellitus (T2DM) is a common metabolic disorder characterized by chronic
hyperglycaemia. It is associated with reduced life expectancy owing to a greater risk of heart …

Type 1 diabetes mellitus (T1DM), also known as autoimmune diabetes, is a chronic disease
characterized by insulin deficiency due to pancreatic β-cell loss and leads to …

Type 2 diabetes mellitus (T2DM) accounts for> 90% of the cases of diabetes in adults.
Resistance to insulin action is the major cause that leads to chronic hyperglycemia in …

In France, prevalence of drug-treated diabetes reached 3.60% in 2005, with 92% of type 2
diabetic patients. In 2007, there are probably nearly 3000 000 diagnosed or undiagnosed …

Type 2 diabetes is a common metabolic disorder characterized by chronic hyperglycaemia.
It is associated with a reduced life expectancy owing to a greater risk of heart disease …

There is a rising worldwide prevalence of diabetes, especially type 2 diabetes mellitus (T 2
DM), which is one of the most challenging health problems in the 21st century. The …

Type 2 diabetes mellitus (T2DM) is a global pandemic, as evident from the global
cartographic picture of diabetes by the International Diabetes Federation (http://www …

Type 2 diabetes is a chronic metabolic disorder that results from defects in both insulin
action and secretion, which is now increasing at pace throughout the world, and its intensity …